Abstract Organizing pneumonia (OP) refers to the pattern of repair/scarring made evident radiologically and histologically in the setting of insult to lung tissue. Secondary OP is due to insults like infection, inhalational injuries, radiation, or drug-induced interstitial disease, while cryptogenic OP (COP) denotes an absence of identifiable insult. Though clinical and radiologic manifestations may be severe, prognosis is generally favorable, with several reviews reporting 5-year mortality 90%, generally rapid responsiveness to glucocorticoid therapy. We present a case of a 64-year-old man without significant past medical history who originally presented with OP’s typical subacute flu-like illness, largely unresponsive to several courses of antibiotics. He transiently improved once started on moderate-dose glucocorticoids, but had worsening respiratory failure within days. Serial imaging demonstrated worsening ground-glass opacities with eventual fibrosis and traction bronchiectasis, while infectious workup, BAL with biopsy, and autoimmune workup remained unrevealing. The diagnosis of COP was made by biopsy of the RML, which was consistent with organizing pneumonia in the absence of malignancy, granulomas, or the presence of other pathologies that would cause OP. Further immunosuppression was pursued at the cost of decompensation in the setting of new Pneumocystis pneumonia despite Bactrim prophylaxis. The patient successfully underwent venovenous-extracorporeal membrane oxygenation (VV-ECMO) cannulation and bilateral lung transplant, with the explanted lungs only revealing diffuse organizing alveolar destruction. He has since made a full recovery and is 14 months post-transplant. This report is intended to discuss early identification of OP, treatment of secondary OP vs. that of COP, and factors that impact course severity, likelihood of relapse, and mortality. Additionally, we discuss the rising role of COVID-19 in delayed manifestations of OP, and address the concern for Pneumocystis pneumonia in the setting of protracted courses of high-dose glucocorticoids. This abstract is funded by: none
Burris et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: